These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 30075311)
1. Nanotherapeutics with suitable properties for advanced anticancer therapy based on HPMA copolymer-bound ritonavir via pH-sensitive spacers. Machová D; Koziolová E; Chytil P; Venclíková K; Etrych T; Janoušková O Eur J Pharm Biopharm; 2018 Oct; 131():141-150. PubMed ID: 30075311 [TBL] [Abstract][Full Text] [Related]
2. Overcoming multidrug resistance in Dox-resistant neuroblastoma cell lines via treatment with HPMA copolymer conjugates containing anthracyclines and P-gp inhibitors. Koziolová E; Janoušková O; Cuchalová L; Hvězdová Z; Hraběta J; Eckschlager T; Sivák L; Ulbrich K; Etrych T; Šubr V J Control Release; 2016 Jul; 233():136-46. PubMed ID: 27189135 [TBL] [Abstract][Full Text] [Related]
3. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line. Kunath K; Kopecková P; Minko T; Kopecek J Eur J Pharm Biopharm; 2000 Jan; 49(1):11-5. PubMed ID: 10613922 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of poly[N-(2-hydroxypropyl)methacrylamide] conjugates of inhibitors of the ABC transporter that overcome multidrug resistance in doxorubicin-resistant P388 cells in vitro. Subr V; Sivák L; Koziolová E; Braunová A; Pechar M; Strohalm J; Kabešová M; Ríhová B; Ulbrich K; Kovář M Biomacromolecules; 2014 Aug; 15(8):3030-43. PubMed ID: 24978588 [TBL] [Abstract][Full Text] [Related]
6. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck. Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307 [TBL] [Abstract][Full Text] [Related]
7. Overcoming multidrug resistance via simultaneous delivery of cytostatic drug and P-glycoprotein inhibitor to cancer cells by HPMA copolymer conjugate. Sivak L; Subr V; Tomala J; Rihova B; Strohalm J; Etrych T; Kovar M Biomaterials; 2017 Jan; 115():65-80. PubMed ID: 27886555 [TBL] [Abstract][Full Text] [Related]
8. Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance. Braunová A; Kostka L; Sivák L; Cuchalová L; Hvězdová Z; Laga R; Filippov S; Černoch P; Pechar M; Janoušková O; Šírová M; Etrych T J Control Release; 2017 Jan; 245():41-51. PubMed ID: 27871991 [TBL] [Abstract][Full Text] [Related]
9. A possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrier. St'astný M; Strohalm J; Plocová D; Ulbrich K; Ríhová B Eur J Cancer; 1999 Mar; 35(3):459-66. PubMed ID: 10448300 [TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting. Li L; Yang Q; Zhou Z; Zhong J; Huang Y Biomaterials; 2014 Jun; 35(19):5171-87. PubMed ID: 24702960 [TBL] [Abstract][Full Text] [Related]
11. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release. Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512 [TBL] [Abstract][Full Text] [Related]
12. Ability of polymer-bound P-glycoprotein inhibitor ritonavir to overcome multidrug resistance in various resistant neuroblastoma cell lines. Koziolová E; Chytil P; Etrych T; Janoušková O Anticancer Drugs; 2017 Nov; 28(10):1126-1130. PubMed ID: 28901962 [TBL] [Abstract][Full Text] [Related]
13. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. Minko T; Kopecková P; Pozharov V; Kopecek J J Control Release; 1998 Jul; 54(2):223-33. PubMed ID: 9724909 [TBL] [Abstract][Full Text] [Related]
14. Synergistic enhancement of anticancer therapeutic efficacy of HPMA copolymer doxorubicin conjugates via combination of ligand modification and stimuli-response srategies. Li L; Zhou M; Huang Y Int J Pharm; 2018 Jan; 536(1):450-458. PubMed ID: 29237570 [TBL] [Abstract][Full Text] [Related]
16. Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles. Zhou Z; Li L; Yang Y; Xu X; Huang Y Biomaterials; 2014 Aug; 35(24):6622-35. PubMed ID: 24814427 [TBL] [Abstract][Full Text] [Related]
17. Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer. Yang Q; Yang Y; Li L; Sun W; Zhu X; Huang Y ACS Appl Mater Interfaces; 2015 Apr; 7(12):6661-73. PubMed ID: 25775367 [TBL] [Abstract][Full Text] [Related]
18. Micelle-forming HPMA copolymer conjugates of ritonavir bound via a pH-sensitive spacer with improved cellular uptake designed for enhanced tumor accumulation. Koziolová E; Machová D; Pola R; Janoušková O; Chytil P; Laga R; Filippov SK; Šubr V; Etrych T; Pechar M J Mater Chem B; 2016 Dec; 4(47):7620-7629. PubMed ID: 32263818 [TBL] [Abstract][Full Text] [Related]
19. HPMA copolymer-1,5-diazaanthraquinone conjugates as novel anticancer therapeutics. Vicent MJ; Manzanaro S; de la Fuente JA; Duncan R J Drug Target; 2004; 12(8):503-15. PubMed ID: 15621676 [TBL] [Abstract][Full Text] [Related]
20. Cooperativity between free and N-(2-hydroxypropyl) methacrylamide copolymer bound adriamycin and meso-chlorin e6 monoethylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vitro. Lu JM; Peterson CM; Guo-Shiah J; Gu ZW; Peterson CA; Straight RC; Kopecek J Int J Oncol; 1999 Jul; 15(1):5-16. PubMed ID: 10375588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]